Stephen Diamond
Member, Foundation Board of Trustees at William & Mary Law School | New York, New York, United States
Stephen Diamond’s Email & Phone Number
Free account · No credit card · 5 profiles/month
Member, Foundation Board of Trustees at William & Mary Law School in July 2022 - Present
Owner / CEO at SPD Advisors LLC in January 2024 - Present
Interim Chief Business Officer at Corstasis Therapeutics in February 2024 - Present
Head of BD Partnering at GentiBio in August 2024 - Present
Interim Head of Business Development at LEXEO Therapeutics in March 2023 - July 2023
Senior Vice President and General Counsel at Freeline in January 2021 - July 2022
Assistant General Counsel, Business Transactions, M&A at Pfizer in January 2015 - January 2021
Senior Corporate Counsel, M&A at Pfizer in April 2010 - December 2014
Corporate Attorney (Secondment) at Pfizer in December 2008 - March 2010
Associate Director, Debt Capital Markets Transaction Advisory at Barclays Capital in September 2008 - October 2008
Senior Corporate Associate at Milbank LLP in August 2005 - August 2008
FICM Transaction Executions (Secondment) at Citi in June 2007 - December 2007
Division Counsel at American International Group in November 2002 - April 2005
Corporate Associate at Sidley Austin in September 1998 - November 2002
Summer Associate at DLA Piper in May 1997 - August 1997
William & Mary Law School, J.D., January 1995 to January 1998
University of Nairobi, Law, January 1996
New York University, B.A., January 1989 to January 1993
Spur Therapeutics is a clinical-stage biotechnology company focused on developing life-changing gene therapies for debilitating chronic conditions. By optimizing every component of our product candidates, we are improving genetic expression and targeted delivery to realize outsized clinical results. Building on the successes of our potential first-in-class therapy for Gaucher disease, we’re moving from rare diseases toward more widespread conditions, including forms of Parkinson’s and dementia, and even certain cardiovascular diseases. Expanding our impact, and pushing forward to new frontiers of genetic medicine. Toward life-changing therapies, and brighter futures. Toward More™
Discover more about William & Mary Law School
Chief Financial Officer at Spur Therapeutics
Chief Financial Officer at Spur Therapeutics
(May 2022 – Present)
Head of IT at Spur Therapeutics
A Director/Head of IT engaged to transform and scale all aspects of IT from BAU service delivery to future projects, drive funding efficiency and exceed all regulatory requirements for a growing biotech company.
Developing in-house excellence for IT infrastructure, project ma...
Vice President Finance at Spur Therapeutics
Responsible for Finance Operations and FP&A. Key responsibilities include:
Driving Financial Reporting, Budgeting, and Performance processes
Evaluating strategic options and impact on Long Range Plan
Partnering with key vendors; driving negotiations and vendor performance ma...
Chief Scientific Officer, Pharmaceutical R&D strategist and innovator, Board Member
Formerly Freeline Therapeutics
Life Sciences Business Development and Licensing Professional
VP, Head of Business Development and Intellectual Property at Spur Therapeutics
(Apr 2023 – Present)
Chief Technical Operations Officer at Spur Therapeutics
Chief Technical Operations Officer at Spur Therapeutics
(Jun 2021 – Present)
What is Stephen Diamond email address?
Email Stephen Diamond at [email protected] and [email protected]. This email is the most updated Stephen Diamond's email found in 2026.
How to contact Stephen Diamond?
To contact Stephen Diamond send an email to [email protected] or [email protected].
What company does Stephen Diamond work for?
Stephen Diamond works for William & Mary Law School.
What is Stephen Diamond's role at William & Mary Law School?
Stephen Diamond is Member, Foundation Board of Trustees
What industry does Stephen Diamond work in?
Stephen Diamond works in the Pharmaceuticals industry.
